Phase III randomized, double-blind, placebo-controlled evaluation of citalopram for the treatment of hot flashes.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Citalopram (Primary)
- Indications Hot flashes
- Focus Therapeutic Use
- 13 Dec 2016 Biomarkers information updated
- 06 Dec 2010 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 06 Dec 2010 Status changed from active, no longer recruiting to completed as repored by ClinicalTrials.gov.